(2-fluorophenyl)-(4-fluorophenyl)methanone

We are (2-fluorophenyl)-(4-fluorophenyl)methanone CAS:342-25-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 342-25-6
Product Name: (2-fluorophenyl)-(4-fluorophenyl)methanone
Other Name:
(2-fluorophenyl)-(4-fluorophenyl)methanone
2,4-Difluorobenzophenone
2-fluoro-4'-fluorobenzophenone
2,4'-difluorobenzophenol
 
Density: 1.2±0.1 g/cm3
Boiling Point: 308.6±0.0 °C at 760 mmHg
Melting Point: 22-24 °C(lit.)
Molecular Formula: C13H8F2O
Molecular Weight: 218.199
Flash Point: 126.8±17.9 °C
Exact Mass: 218.054321
PSA: 17.07000
LogP: 3.03
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.550
 
Specification
Appearance: White or light yellow solid or liquid
Assay: ≥99.0%
Water: ≤0.3%
 
Application
Intermediates of Flutriafol CAS: 76674-21-0.
Be used as pesticide intermediate, mainly used in the synthesis of the fungicide Flutriafol.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(2-fluorophenyl)-(4-fluorophenyl)methanone


Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde CAS:1228837-05-5 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.5-methyl-2'-deoxycytidine Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.triethoxy(2-methylpropyl)silane CAS:17980-47-1 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.

Related Products
Product Name
4-Bromo-1-chloro-Dibenzofuran Cas:2183475-72-9 View Details
1,2,3,4-TETRAHYDRO-2-NAPHTHOL Cas:530-91-6 View Details
Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)-butanoic Acid Cas:486460-00-8 View Details
[phenyl-(2,2,2-trifluoroacetyl)oxy-λ<sup>3</sup>-iodanyl] 2,2,2-trifluoroacetate manufacturer polyglycerol-10 laurate Cas:34406-66-1 manufacturer decabromodiphenyl ethane Cas:84852-53-9 manufacturer titanium Oxysulfate Cas:13825-74-6 manufacturer 2-[(4-chlorophenyl)methyl]-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-1-one manufacturer